Top Markets
Coin of the day
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

AOBI
Rang în acțiuni #42790
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China,... American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
Preț acțiune
$0.0012
Ultima sincronizare: 2026-08-11
Capitalizare de piață
$88.00
Schimbare (1 zi)
0.00%
Schimbare (1 an)
140.00%
Țară
CN
Tranzacționează American Oriental Bioengineering, Inc. (AOBI)

Categorie

Prețul AOBI cu capitalizarea de piață a B
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
AOBI
$0.0012
Capitalizarea de piață a American Oriental Bioengineering, Inc.(AOBI)
Capitalizare de piață: $88.00
În anul August 2026, American Oriental Bioengineering, Inc. are o capitalizare de piață de $88.00. Acest lucru face ca American Oriental Bioengineering, Inc. să fie a 42790th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a American Oriental Bioengineering, Inc. din 2001 până în 2026
AOBI în comparație cu top 5 cele mai populare stocks
Prețul pentru AOBI Activul B Capitalizarea de piață a B Rezultate
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$73,991,089 $88.00
$5.426T +6,165,924,076,240.12%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$60,367,310 $88.00
$4.427T +5,030,609,198,078.17%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$56,440,477 $88.00
$4.139T +4,703,373,118,931.22%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$49,855,368 $88.00
$3.656T +4,154,613,985,903.35%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$39,349,895 $88.00
$2.886T +3,279,157,928,458.77%